Allali G

References (9)

Title : Brain health services for the secondary prevention of cognitive impairment and dementia: Opportunities, challenges, and the business case for existing and future facilities - Frisoni_2025_J.Prev.Alzheimers.Dis__100098
Author(s) : Frisoni GB , Ribaldi F , Allali G , Bieth T , Brioschi Guevara A , Cappa S , Cipolotti L , Frederiksen KS , Georges J , Jessen F , Koch G , Masters H , Mendes AJ , Frolich L , Garibotto V , Grau-Rivera O , Pozzi FE , Religa D , Rostamzadeh A , Shallcross L , Shenkin SD , van der Flier WM , Vernooij MW , Visser LNC , Cummings JL , Scheltens P , Dubois B , Moro E , Bassetti CLA , Kivipelto M
Ref : J Prev Alzheimers Dis , :100098 , 2025
Abstract :
PubMedSearch : Frisoni_2025_J.Prev.Alzheimers.Dis__100098
PubMedID: 40102145

Title : Management of Gait Changes and Fall Risk in MCI and Dementia - Allali_2017_Curr.Treat.Options.Neurol_19_29
Author(s) : Allali G , Verghese J
Ref : Curr Treat Options Neurol , 19 :29 , 2017
Abstract :
PubMedSearch : Allali_2017_Curr.Treat.Options.Neurol_19_29
PubMedID: 28733759

Title : Anti-Dementia Drugs, Gait Performance and Mental Imagery of Gait: A Non-Randomized Open-Label Trial - Beauchet_2016_Drugs.Aging_33_665
Author(s) : Beauchet O , Barden J , Liu-Ambrose T , Chester VL , Annweiler C , Szturm T , Grenier S , Leonard G , Bherer L , Allali G
Ref : Drugs & Aging , 33 :665 , 2016
Abstract :
PubMedSearch : Beauchet_2016_Drugs.Aging_33_665
PubMedID: 27568453

Title : Anti-dementia drugs-related changes in gait performance while single and dual tasking in patients with Alzheimer disease: a meta-analysis - Beauchet_2015_Curr.Alzheimer.Res_12_761
Author(s) : Beauchet O , Launay CP , Montero-Odasso M , Annweiler C , Allali G
Ref : Curr Alzheimer Res , 12 :761 , 2015
Abstract :
PubMedSearch : Beauchet_2015_Curr.Alzheimer.Res_12_761
PubMedID: 26159199

Title : Changes in Gait Variability with Anti-dementia Drugs: A Systematic Review and Meta-analysis - Beauchet_2014_CNS.Drugs_28_513
Author(s) : Beauchet O , Launay CP , Allali G , Annweiler C
Ref : CNS Drugs , 28 :513 , 2014
Abstract :
PubMedSearch : Beauchet_2014_CNS.Drugs_28_513
PubMedID: 24806974

Title : Gait changes with anti-dementia drugs: a prospective, open-label study combining single and dual task assessments in patients with Alzheimer's disease - Beauchet_2014_Drugs.Aging_31_363
Author(s) : Beauchet O , Launay CP , Allali G , Herrmann FR , Annweiler C
Ref : Drugs & Aging , 31 :363 , 2014
Abstract :
PubMedSearch : Beauchet_2014_Drugs.Aging_31_363
PubMedID: 24683126

Title : Anti-dementia drugs and changes in gait: a pre-post quasi-experimental pilot study - Beauchet_2013_BMC.Neurol_13_184
Author(s) : Beauchet O , Launay C , Allali G , Watfa G , Gallouj K , Herrmann F , Annweiler C
Ref : BMC Neurol , 13 :184 , 2013
Abstract :
PubMedSearch : Beauchet_2013_BMC.Neurol_13_184
PubMedID: 24261605

Title : Galantamine improves gait performance in patients with Alzheimer's disease -
Author(s) : Assal F , Allali G , Kressig RW , Herrmann FR , Beauchet O
Ref : J Am Geriatr Soc , 56 :946 , 2008
PubMedID: 18454755

Title : [Alzheimer's disease: therapeutic perspectives] - Dubois_2008_Bull.Acad.Natl.Med_192_333
Author(s) : Dubois B , De Souza L , Allali G , Kalafat M , Sarazin M
Ref : Bull Acad Natl Med , 192 :333 , 2008
Abstract :
PubMedSearch : Dubois_2008_Bull.Acad.Natl.Med_192_333
PubMedID: 18819687